UCHL1 appears, therefore, to reflect an earlier biochemical milieu, occurring before the onset of overt neurodegeneration that characterizes the peri‐symptomatic phase of ALS and FTD. The gene discussed is UCHL1; the disease is frontotemporal dementia.